強気
$709.68
シナリオ価格
$512.380
-3.023 (-0.59%)終値時点
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers.
Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.
UBS
$650
2026-09-25
UBS
2026-09-25
目標株価
$650
Oppenheimer
$590
2026-07-31
Oppenheimer
2026-07-31
目標株価
$590
RBC Capital
$548
2026-07-30
RBC Capital
2026-07-30
目標株価
$548
BofA
$510
2026-07-09
BofA
2026-07-09
目標株価
$510
RBC Capital
$436
2026-04-27
RBC Capital
2026-04-27
目標株価
$436
シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。
Key Wall Street Calls on Friday

Chemed Executive Sells 1,000 Shares, Reducing Holdings by 7%

Chemed Executive Sells Shares, Reducing Holdings by 7%

Chemed Corp Options Trading Activity Surges

Biotech Stocks Reach 52-Week Highs Driven by Strong Earnings
Chemed Corporation is engaged in purchasing, operating, and divesting subsidiaries in diverse business activities. The Company's segment includes VITAS and the Roto-Rooter. The VITAS segment provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. It provides direct medical services to patients, as well as spiritual and emotional counseling to both patients and their families. The Roto-Rooter segment provides plumbing, drain cleaning, excavation, water restoration and other related services to residential and commercial customers. The Roto-Rooter services are provided through a network of Company-owned branches, independent contractors and franchisees. The Company's water restoration services involve the remediation of water and humidity after a flood and are provided to both commercial and residential customers. It operates in the Healthcare sector (SERVICES-HOME HEALTH CARE SERVICES industry).
Chemed Corp is a good buy right now due to its current price of $512.38, which is below the median analyst price target of $549, indicating a potential upside of 7.1%. Additionally, the company has shown a strong year-to-date change of +20.90%, reflecting solid performance. However, a risk to consider is the insider selling activity, where an executive sold 1,000 shares, reducing holdings by 7%, which could signal caution among insiders.
4 analysts cover CHE: 1 rate it Buy, 3 Hold and 0 Sell. The average price target is 547.33.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。